Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.

Citation metadata

Publisher: Frontiers Research Foundation
Document Type: Brief article
Length: 337 words
Lexile Measure: 1670L

Document controls

Main content

Source Citation

Source Citation   

Gale Document Number: GALE|A674822690